China NMPA Inspections: Making Your Way Through a Complex Affair

ARTICLE SUMMARY:

China’s regulatory agency is doing more inspections at device facilities around the world, and National Medical Products Administration audits are logistically more complex than an FDA inspection. Here are survival tips from Vy Tran, who leads regulatory operations at Varian Medical Systems, which recently hosted NMPA auditors at its Palo Alto facility.

The frequency and vigor of device facility inspections from China’s National Medical Products Administration are growing, not only within China but overseas as well. No matter where you are manufacturing your devices, if you are selling in the rapidly growing Chinese market, you need to be ready for NMPA auditors to show up at your door.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite

Questions?

We're here to help! Please contact us at: